Thiazolinone unsubstituted quinolines

Details for Australian Patent Application No. 2005259512 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Chen, Li; Chen, Shaoqing

Agent Davies Collison Cave

Pub. Number AU-A-2005259512

PCT Pub. Number WO2006/002829

Priority 60/584,746 01.07.04 US; 60/629,495 19.11.04 US

Filing date 23 June 2005

Wipo publication date 12 January 2006

International Classifications

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/002829 Priority application(s): WO2006/002829

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259523-Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant

2005259511-Quinoline thiazolinones with CDK1 antiproliferative activity